Bayer AG
XETRA:BAYN
Bayer AG
Other Liabilities
Bayer AG
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Other Liabilities
€14.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Liabilities
$11.2m
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Other Liabilities
€2.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
MPH Health Care AG
XETRA:93M1
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Liabilities
€144.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Other Liabilities
€166k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Other Liabilities?
Other Liabilities
14.8B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Other Liabilities amounts to 14.8B EUR.
What is Bayer AG's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
4%
Over the last year, the Other Liabilities growth was -10%. The average annual Other Liabilities growth rates for Bayer AG have been -1% over the past three years , and 4% over the past ten years .